Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EarkartBOM:544549 19 EBITDA Margin % is 16.69% as of Mar. 2026, which is 47% above its 10-year median of 11.36. GuruFocus rates BOM:544549 with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Earkart ranks better than 69.73% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Earkart's EBITDA for the
six
months ended in Mar. 2026 was ₹53.0 Mil. Earkart's Revenue for the
six
months ended in Mar. 2026 was ₹317.5 Mil. Therefore, Earkart's EBITDA margin for the quarter that ended in Mar. 2026 was 16.69%.
Earkart (BOM:544549) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Earkart EBITDA Margin % Related Terms
Earkart EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Earkart's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earkart EBITDA Margin % Chart
Earkart Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
EBITDA Margin %
3.12
5.59
11.36
22.88
15.87
Earkart Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
EBITDA Margin %
0.00
0.00
0.00
0.00
16.69
BOM:544549 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Earkart's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earkart EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Earkart's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Earkart's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earkart (BOM:544549) has a EBITDA Margin % of 16.69% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Earkart and its competitors. This is 47% above median its historical median of 11.36. Over the past decade, Earkart's EBITDA Margin % has ranged from 3.12 to 22.88. According to the industry distribution chart, Earkart ranks #247 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 30.3%.
Is Earkart's EBITDA Margin % too high?
Earkart's current EBITDA Margin % of 16.69% is 47% above median its 10-year median of 11.36. Over the past 10 years, this metric has ranged from a low of 3.12 to a high of 22.88. The Medical Devices & Instruments industry median EBITDA Margin % is 7.46. Earkart's value of 16.69% is 123.9% above this industry median. Based on the distribution chart, Earkart ranks #247 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Earkart has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Earkart's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Earkart ranks #247 out of 816 companies for EBITDA Margin %. This puts Earkart in the upper half of its industry. The industry median EBITDA Margin % is 7.46. Earkart's value of 16.69% is 123.9% above this benchmark. Historically, Earkart's own EBITDA Margin % has ranged from 3.12 to 22.88 over the past decade. While the company's 10-year median is 11.36 vs. the industry median of 7.46, Earkart has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earkart's current EBITDA Margin % of 16.69% is 123.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Earkart and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earkart's current EBITDA Margin % is 16.69%, which is 47% above median its own 10-year median of 11.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earkart stock overvalued right now?
Earkart (BOM:544549) has a current EBITDA Margin % of 16.69%. The current EBITDA Margin % is 16.69%, which is 47% above median its 10-year median of 11.36 and 123.9% above the Medical Devices & Instruments industry median of 7.46. Earkart's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Earkart (BOM:544549), the current EBITDA Margin % is 16.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Earkart Ltd is a hearing care company based in India that manufactures and distributes modern hearing aids and related accessories at affordable prices. The company also trades in hearing aids and parts from both Indian and foreign brands. Earkart has expanded its product range to include mobility aids like adjustable foldable walkers and therapy kits for children with disabilities. It developed a remote audiometry machine operated by audiologists to facilitate hearing tests remotely, improving access to hearing care services across India. Earkart operates through a wide network of clinics and hearing solution dispensers, blending manufacturing with a customer-focused approach to reach underserved regions.
19GF Score
Get the complete analysis for BOM:544549
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544549 has been successfully added to your 
